Dieter Weinand is the former CEO of Bayer Pharma AG, and is an experienced business leader with over 25 years of experience in the pharmaceutical industry. He earned an M.S. in pharmacology and toxicology from Long Island University, New York, and a B.A. in biology from Concordia College, New York. During his career, he has held various responsibilities in general management, commercial, operational and strategic leadership roles, leading business operations globally, for companies including Bayer, Pfizer, Bristol-Myers Squibb, and Sanofi. He has also led the launch and marketing of products across primary care, specialty care, and oncology therapeutic areas. He is currently Chairman of the Board of Replimune (REPL), Member of the Board of Directors FieldTrip Health (FTRPF), Chairman of the Board of Directors of Ammune, and Executive Chairman of the Board of ZielBioPharma.
